These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21142764)

  • 1. HHS guidance on synthetic DNA is the right step.
    Gronvall GK
    Biosecur Bioterror; 2010 Dec; 8(4):373-6. PubMed ID: 21142764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening Security for Gene Synthesis: Recommendations for Governance.
    Kobokovich A; West R; Montague M; Inglesby T; Gronvall GK
    Health Secur; 2019; 17(6):419-429. PubMed ID: 31755783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological agents. New U.S. rules set the stage for tighter security, oversight.
    Malakoff D
    Science; 2002 Dec; 298(5602):2304. PubMed ID: 12493881
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic Biology, Genome Editing, and the Risk of Bioterrorism.
    Ahteensuu M
    Sci Eng Ethics; 2017 Dec; 23(6):1541-1561. PubMed ID: 28074376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosecurity. New biosecurity rules to target the riskiest pathogens.
    Bhattacharjee Y
    Science; 2010 Jul; 329(5989):264-5. PubMed ID: 20647433
    [No Abstract]   [Full Text] [Related]  

  • 6. California shows the way for biosecurity in commercial gene synthesis.
    West R; Gronvall GK
    Nat Biotechnol; 2020 Sep; 38(9):1021. PubMed ID: 32811990
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioterrorism. Congress adopts tough rules for labs.
    Malakoff D
    Science; 2002 May; 296(5573):1585-7. PubMed ID: 12040151
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic biology: regulating industry uses of new biotechnologies.
    Erickson B; Singh R; Winters P
    Science; 2011 Sep; 333(6047):1254-6. PubMed ID: 21885775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Health and biosecurity. The limits of government regulation of science.
    Kraemer JD; Gostin LO
    Science; 2012 Mar; 335(6072):1047-9. PubMed ID: 22267583
    [No Abstract]   [Full Text] [Related]  

  • 10. Hands-On Introduction to Synthetic Biology for Security Professionals.
    Adames NR; Gallegos JE; Hunt SY; So WK; Peccoud J
    Trends Biotechnol; 2019 Nov; 37(11):1143-1146. PubMed ID: 31320118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the Synthetic Biology Industry: Implications for Biosecurity.
    Carter S; DiEuliis D
    Health Secur; 2019; 17(5):403-406. PubMed ID: 31593512
    [No Abstract]   [Full Text] [Related]  

  • 12. Biodefense. House passes plan for drug, vaccine R&D.
    Kaiser J
    Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of biological research in the terrorism era.
    Kellman B
    Health Matrix Clevel; 2003; 13(1):159-80. PubMed ID: 14569661
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioterrorism and biological threats dominate federal health security research; other priorities get scant attention.
    Shelton SR; Connor K; Uscher-Pines L; Pillemer FM; Mullikin JM; Kellermann AL
    Health Aff (Millwood); 2012 Dec; 31(12):2755-63. PubMed ID: 23213160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Throwing money at biodefense.
    DeFrancesco L
    Nat Biotechnol; 2004 Apr; 22(4):375-8. PubMed ID: 15060542
    [No Abstract]   [Full Text] [Related]  

  • 16. Strengths and limitations of the federal guidance on synthetic DNA.
    Adam L; Kozar M; Letort G; Mirat O; Srivastava A; Stewart T; Wilson ML; Peccoud J
    Nat Biotechnol; 2011 Mar; 29(3):208-10. PubMed ID: 21390018
    [No Abstract]   [Full Text] [Related]  

  • 17. Biodefense funding: changes from president's budget to congressional appropriations.
    Sell TK; Gilles K; Franco C
    Biosecur Bioterror; 2012 Sep; 10(3):321-7. PubMed ID: 22897593
    [No Abstract]   [Full Text] [Related]  

  • 18. HHS draft guidance on financial conflicts of interest.
    Barnes M; Gallin K
    IRB; 2003; 25(5):15-6. PubMed ID: 14870740
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic DNA firms embrace hazardous agents guidance but remain wary of automated 'best-match'.
    Eisenstein M
    Nat Biotechnol; 2010 Dec; 28(12):1225-6. PubMed ID: 21139590
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical and regulatory challenges posed by synthetic biology.
    Rager-Zisman B
    Perspect Biol Med; 2012; 55(4):590-607. PubMed ID: 23502567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.